Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
6.83
+0.10 (1.49%)
At close: Aug 1, 2025, 4:00 PM
6.83
0.00 (0.00%)
After-hours: Aug 1, 2025, 6:04 PM EDT

Accolade Stock Forecast

Stock Price Forecast

The 8 analysts that cover Accolade stock have a consensus rating of "Buy" and an average price target of $7.13, which forecasts a 4.39% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $12.

Price Target: $7.13 (+4.39%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$2.00$7.13$9.00$12
Change-70.72%+4.39%+31.77%+75.70%

Analyst Ratings

The average analyst rating for Accolade stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy111001
Buy222333
Hold555333
Sell111111
Strong Sell000000
Total999778

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Hold
Maintains
$4$5
HoldMaintains$4$5-26.79%Jul 30, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Upgrades
$4$12
Strong BuyUpgrades$4$12+75.70%Jul 29, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$6$9
BuyMaintains$6$9+31.77%May 29, 2025
Leerink Partners
Leerink Partners
Buy
Upgrades
$4$12
BuyUpgrades$4$12+75.70%May 23, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Upgrades
$10
BuyUpgrades$10+46.41%May 15, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 80.00M
Revenue Next Year
n/a
EPS This Year
-1.19
from -0.16
EPS Next Year
-1.23
from -1.19
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
8.82M19.16M6.34M2.81M80.00M---
Revenue Growth
-117.19%-66.91%-55.77%2,752.05%---
EPS
-2.79-2.29-2.44-1.59-0.16-1.19-1.23-1.01
EPS Growth
--------
Forward PE
--------
No. Analysts
-----9106
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/an/a
Avgn/an/an/a
Lown/an/an/a

Revenue Growth

Revenue Growth20252026202720282029
High---
Avg---
Low---

EPS Forecast

EPS20252026202720282029
High-1.14-1.09-0.68
Avg-1.19-1.23-1.01
Low-1.20-1.40-1.26

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.